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Transcription elongation is a critical regulatory step in the gene expression cycle. One key regulator of the 
switch between transcription initiation and elongation is the P-TEFb kinase, which phosphorylates RNA 
polymerase II (Pol II) and several negative elongation factors to relieve the elongation block at paused promoters 
to facilitate productive elongation. Here, we highlight recent findings signifying the role of the PPM1G/PP2C 
phosphatase in activating and maintaining the active transcription elongation state by regulating the availability 
of P-TEFb and blocking its assembly into the catalytic inactive 7SK small nuclear ribonucleoprotein (snRNP) 
complex. 
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Introduction 
Studies over the past three decades have provided insights 
into the importance of transcription regulatory mechanisms 
in metazoan cells. RNA polymerase II (Pol II) activity can be 
regulated at several steps of the transcription cycle including 
pre-initiation, DNA melting, initiation, promoter clearance, 
and elongation [1-7]. It has, more recently, became 
well-established in the field that transcription elongation 
control is vital for the regulation of several key biological 
processes including response to environmental cues, cell fate 
choice, differentiation, and development. Transcription 
elongation is precisely regulated by the action of two sets of 
elongation factors (negative and positive) that dictate 
transcriptional pausing and pause release, respectively. 
Sequence-specific transcription factors utilize co-regulators 
(co-activators and co-repressors), large protein complexes 
carrying enzymatic activities, to precisely modulate one or 
more steps in the transcription cycle. Great progress has been 
made in identifying several transcriptional co-regulators and 
in describing their critical importance for Pol II transcription 
such as acetyl transferases, deacetylases, kinases and 
phosphatases, among others [8]. Here, we discuss the 
discovery of a novel transcriptional co-regulator, mechanistic 
insights into its role in promoting transcription elongation 
and future challenges. 
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Transcriptional pausing 
Promoter-proximal Pol II pausing is a key rate-limiting 
and highly regulated step in the transcription cycle. 
Genome-wide analysis in metazoan cells showed that the 
major form of Pol II is bound to promoter-proximal regions 
and poised for rapid entry into productive elongation [9-12]. 
Notably, Pol II pausing is prevalent at genes involved in 
development and response to stimuli, suggesting that 
transcriptional pausing during early elongation plays 
important, variable, and regulated rate-limiting roles in the 
rapid and precise control of gene expression [13,14]. 
Figure 1. Transcription steps con- trolling Pol II 
pausing and pause release. A. The transcription 
pre-initiation complex (PIC), composed of Pol II and 
additional general transcription factors (not shown for 
simplicity), assemble on the template DNA before the 
transcription start site (TSS). The largest subunit of 
Pol II contains a C-terminal domain (CTD) composed 
of 52 heptad repeats with the consensus sequence 
YSPTSPS where Ser2 (S2), Ser5 (S5) and Ser7 (S7) 
serve as acceptor sites for multiple kinases. B. The 
TFIIH complex (containing the Cdk7 kinase) 
phosphorylates Ser5 residues on the CTD (S5P) to 
facilitate initiation and promoter clearance. C. Upon 
synthesis of a short RNA chain (>18 nt-long, shown in 
red), TFIIH is evicted and the negative elongation 
factors DSIF and NELF are recruited through 
cooperative interactions with nascent RNA and Pol II 
to promote pausing. D. P-TEFb is recruited to Pol II 
and phosphorylates NELF (which is evicted from the 
DSIF-Pol II complex) in addition to DSIF and Pol II, 
which together facilitate Pol II pause release. 
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After transcription initiation and promoter clearance due 
to the action of the TFIIH kinase, Pol II pauses between the 
transcription start site (TSS) and the +1 nucleosome after 
transcribing a short (~20-60 nt) RNA chain by the action of 
negative elongation factors (Figure 1). There are two major 
negative elongation factors: 
5,6-dichloro-1-β-D-ribofuranosyl-benzimidazole (DRB) 
sensitivity-inducing factor (DSIF) and Negative Elongation 
Factor (NELF), which interact with early elongation 
complexes to halt elongation and induce transcriptional 
pausing. Most metazoan genes require cooperative inhibition 
by DSIF and NELF for robust Pol II pausing and gene 
activation [15]. Interestingly, levels of DSIF and NELF at 
promoter-proximal regions directly correlate with total Pol II 
occupancy levels, suggesting that these factors associate with 
most early elongation complexes [4], and at most Pol II 
regulated genes thus implying a general role in controlling 
pausing [9, 10, 12]. 
DSIF is composed of two subunits (p160 and p14), which 
are the human homologues of Saccharomyces cerevisiae 
Spt5/Spt4 factors. DSIF was first identified by Wada et al. 
using HeLa cell nuclear extracts for factors that cause 
pausing of Pol II in conjunction with the transcription 
inhibitor DRB [16-18]. In addition to its negative function in 
elongation, Wada et al. found that DSIF associated with Pol 
II and stimulated the rate of elongation by Pol II in vitro in a 
reaction containing limiting nucleotides [16, 19]. 
Similarly, using an elegant biochemical approach, 
Yamaguchi et al. described the identification and purification 
from HeLa nuclear extracts of a factor required for 
DRB-sensitive transcription and they referred to it as NELF 
[20]. NELF is composed of five polypeptides (NELF-A, -B, 
-C/D and -E), the smallest (NELF-E) of which is identical to
the RNA-binding protein RD, and whose RNA-binding
activity is critical for NELF function as negative elongation
factor [21]. Upon NELF recruitment to Pol II at
promoter-proximal regions, NELF inhibits Pol II activity by
binding the nascent RNA chain and preventing further
elongation [15,20].
While DSIF binds Pol II directly and stably without 
affecting its polymerase activity, NELF does not bind Pol II 
directly and is recruited to early elongation complexes 
through DSIF. Although the details of the 
interaction/recruitment mechanism are still unclear, one 
possibility is that the negative elongation function of 
DSIF/NELF could be related to their ability to bind the 
nascent RNA. Particularly, NELF-E and Spt5 are both 
known to interact with the short RNA transcript emerging 
from Pol II after transcription initiation and thus inhibit 
productive elongation [21-23] (Figure 1). Crosslinking 
experiments suggest that Spt5 contacts the nascent RNA as it 
emerges from the elongation complex and subsequently 
recruits NELF [23]. Both DSIF and NELF require a nascent 
RNA chain (>18 nt-long) to stably associate with the Pol II 
elongation machinery [23], in agreement with a lack of 
evidence for a role of DSIF/NELF in initiation and promoter 
clearance [20]. 
Using permanganate genomic footprinting, Lee et al. 
found that most genes marked by NELF in Drosophila also 
showed evidence of paused Pol II at promoter-proximal 
regions (+30 to +50 bp from the TSS) and proposed that 
NELF-mediated Pol II pausing might be an obligatory but 
sometimes transient checkpoint during the transcription cycle 
[24]. Similarly, Rahl et al. has shown that NELF and DSIF 
co-occupy most Pol II regulated promoter-proximal regions 
of transcriptionally active but paused genes in mouse 
embryonic stem cells [12]. 
Although a subset of NELF target genes in Drosophila 
(like Hsp70) are up-regulated by NELF genetic depletion, the 
majority show decreased expression levels, suggesting that 
the presence of paused Pol II might enhance gene expression 
by maintaining a permissive chromatin architecture around 
the promoter-proximal region. Additionally, the loss of Pol II 
stalling at these promoters is accompanied by a significant 
increase in nucleosome occupancy and a decrease in the 
active chromatin signatures surrounding the TSS [25]. In fact, 
in 2010 Gilchrist et al. provided compelling evidence for a 
key role of paused Pol II in competing with nucleosomes for 
occupancy of highly regulated promoters, thereby preventing 
the formation of repressive chromatin architecture to 
facilitate further or future gene activation [26]. 
Several genomic approaches in Drosophila and mammals 
have supported the model that NELF associates only with the 
5’ end of genes, while DSIF travels with elongating Pol II 
since it is detected throughout the transcribing unit [9, 10, 15, 24, 
25]. For example, at the Drosophila hsp70 locus, following 
heat shock stimulation, DSIF and Pol II but not NELF were 
strongly recruited to chromosomal puffs harboring the hsp70 
genes. Thus, both NELF and DSIF cause Pol II to pause in 
the promoter-proximal region, and the transcriptional 
activator heat shock factor (HSF) might cause NELF to 
dissociate from the elongation complex, and DSIF to travel 
with elongating Pol II. 
Compared to the regulation in metazoan cells, the 
evidence for Pol II pausing is lacking in S. cerevisiae. NELF 
orthologues are conserved from Drosophila to humans, but 
absent in budding yeast [24], thus suggesting a more complex 
regulatory network as species evolved. In fact, phylogenetic 
analyses of components of the elongation control machinery 
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indicate that the number of mechanisms utilized to regulate 
P-TEFb function increase as organisms show more complex 
developmental patterns [27]. 
Several additional factors are known to control Pol II 
pausing. For example, GDOWN1 (a sub-stoichiometric Pol 
II subunit shown previously to render it responsive to 
Mediator) blocks the general transcription factor TFIIF and 
stabilizes paused Pol II at promoter-proximal regions of most 
human genes [28]. There are several excellent reviews 
discussing the roles of GDOWN1 and other regulators in 
transcription elongation control. In this review article, we 
focus on the newly discovered PPM1G/PP2C phosphatase 
[29,30] and its functional interplay with the early elongation 
machinery in the control of Pol II pausing and pause release. 
Transcriptional pause release 
Promoter-proximal Pol II pausing is relieved by the action 
of positive transcription elongation factors. One of these key 
factors is the positive transcription elongation factor b 
(P-TEFb), a hetero-dimer of a cyclin subunit and 
cyclin-dependent kinase 9 (Cdk9). The regulatory cyclin 
(Cyc) subunit associated with Cdk9 is usually CycT1 or 
CycT2 and in some cases CycK [27, 31, 32]. Cdk9 exists in two 
functional isoforms (a major 42 kDa form and a minor 55 
kDa form) both of which associate with a cyclin subunit [33]. 
P-TEFb phosphorylates the C-terminal domain (CTD) of the 
largest subunit of Pol II and negative elongation factors 
(DSIF and NELF) to promote the escape into productive 
elongation (also known as transcriptional pause release) [22,
27, 34, 35]. 
P-TEFb phosphorylates the Spt5 subunit of DSIF on 
C-terminal repeats (consensus = G-S-R/Q-T-P) to promote 
processive transcription elongation [35]. With difference to the 
Pol II CTD residues phosphorylated by P-TEFb (Ser2 and 
Ser5), phosphorylation of Thr4 on the C-terminal repeats of 
Spt5 promote the elongation activity of DSIF. This 
phosphorylation event converts DSIF from a repressor to an 
activator and is thought to function in a manner analogous to 
the phosphorylated CTD (serving as an additional code for 
active elongation complexes) [35]. Despite this remarkable 
discovery, it remains unclear how Spt5 phosphorylation 
contribute to the elongation process. It is likely that it may 
interact with different factors (protein and RNA) at 
promoter-proximal regions to relieve repressive associations 
with NELF or other negative factors in the early elongation 
complex. 
In addition to DSIF and NELF, the primary target of 
P-TEFb is the Pol II CTD, which is an unusual polypeptide 
extension appended to the largest subunit (Rpb1). The CTD 
is inherently disordered and serves as a flexible binding 
scaffold for numerous protein interactions throughout the 
transcription cycle. In metazoans, the CTD comprises from 
25 to 52 tandem copies of the consensus heptad repeat 
YSPTSPS. The repeats are post-translationally modified in 
almost every residue to orchestrate the association of 
different sets of factors with the transcript and influence the 
functional organization of the nucleus. Although recent in 
vitro studies have suggested that P-TEFb primarily targets 
Ser5 and Ser7 residues [36], in vivo studies showed that Ser2 
phosphorylation is more strongly affected upon Cdk9 
inhibition [18, 37]. However, Cdk9 inhibition with DRB and 
flavopiridol can target several kinases, albeit with different 
affinities. 
Despite the critical role of Cdk9 in the control of 
transcriptional pause release, other kinases (Cdk7, Cdk12, 
and Cdk13) have been implicated in CTD phosphorylation 
and the control of Pol II pause release and RNA processing. 
With the goal of keeping this review focused on the interplay 
between Cdk9 and the novel kinase regulator (PPM1G) here 
we include references to fundamental articles discussing 
roles of other CTD kinases in transcription control [38-41]. 
Taken together, mechanisms regulating Pol II pause 
release are vast and primarily rely on direct control of 
P-TEFb, which can be recruited to chromatin through 
interactions with different factors and probably in different 
catalytic states (active or primed) to phosphorylate its 
substrates at target genomic sites. 
Control of transcriptional pause release by the 7SK 
snRNP complex 
Given the role of P-TEFb in pause release and the 
coupling between RNA processing and transcription 
elongation at most genes, mechanisms that control P-TEFb 
activity are of critical importance. These mechanisms include 
regulation of kinase expression, translation, and turnover [31,
42, 43]. However, the most unique and well-studied mechanism 
of P-TEFb regulation is through the reversible association 
with the 7SK small nuclear ribonucleoprotein (snRNP) 
complex. In rapidly growing cells, a large fraction of P-TEFb 
(up to 90%) exists in a catalytically inactive form assembled 
into the 7SK snRNP [44], which is composed of the 7SK 
RNA, P-TEFb, the kinase inhibitor Hexim 1 and/or 2 (here 
referred as to Hexim for simplicity), the 5’-RNA methyl 
capping enzyme MePCE, and the 3’-RNA stability protein 
Larp7 [45-51] (Figure 2). 
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The human 7SK RNA is a 331 nt-long, abundant 
non-coding RNA synthesized by Pol III, and composed of 
four hairpins/stem loops (stems I, II, III and IV) [52]. Previous 
reports have shown that MePCE interacts with the 
proximal-region of stem I and Larp7 binds to the U-rich tail 
region and other sites of the 3’-terminal stem IV [45, 47]. 
MePCE and Larp7 form the core components of the 7SK 
snRNP and provide structural stability for the 7SK snRNA 
and the snRNP complex [47, 53, 54] (Figure 2). 
The distal portion of 7SK stem I contains two structurally 
similar motifs, which function in the binding of Hexim1/2 
homo- or hetero-dimers in vitro and in vivo [55, 56]. The distal 
part of stems I and IV contain all necessary elements 
required for P-TEFb recruitment [57]. Binding to 7SK RNA 
causes a conformational change in Hexim that allows it to 
interact with the CycT1 subunit allowing it to recruit 
P-TEFb, thus assembling the 7SK snRNP complex and 
inhibiting Cdk9 kinase activity [49, 58-61]. Systematic 7SK 
RNA mutagenesis showed that alterations in Hexim binding 
abolishes P-TEFb’s recruitment thereby indicating its 
absolute requirement in formation of the 7SK snRNP [57]. 
Moreover, 7SK snRNP assembly requires phosphorylation of 
the Cdk9 T-loop (at residue T186), which promotes 
interactions with Hexim and 7SK RNA in vitro [48]. 
In Hexim, two coiled-coiled regions [CCR1 (279-315) and 
CCR2 (319-352) in the C-terminus] and a basic 
RNA-binding motif (KKKHRRRP) that contacts 7SK RNA 
in a P-TEFb–independent manner are involved in assembling 
the 7SK snRNP complex to inactivate the kinase [57]. The 
CCR2 motif mediates Hexim homo-dimerization resulting in 
the recruitment of P-TEFb through the CCR1 region [58, 59]. 
Although the molecular details for the protein-RNA 
interactions are well established, the lack of a high-resolution 
structure so far impedes the better understanding of the 
assembly and kinase inactivation processes. 
Although the majority of the 7SK snRNP complex exists 
in the soluble nucleoplasmic fraction, previous studies have 
shown that the snRNP is recruited to promoter-proximal 
regions [29, 62-64], probably to deliver primed kinase for ‘on 
site’ activation [65]. These discoveries were initially seen to 
be controversial in the field because of the low crosslinking 
efficiency of 7SK snRNP components compared to factors 
directly bound to chromatin. Particularly because, 
biochemically, 7SK snRNP appears not to be stably 
associated with chromatin and can freely diffuse in the 
nucleus, as demonstrated by its extraction using mild 
conditions (low detergent and salt concentrations) [44, 66]. 
However, several studies by our group and others have 
extended those initial discoveries by providing compelling 
evidence that components of the 7SK snRNP complex are 
recruited to genomic domains including promoters and 
cellular enhancers to control transcription elongation [29, 64, 65, 
67]. Thus, the presence of P-TEFb as part of the 7SK snRNP 
complex at gene promoters correlates with the degree to 
which Pol II pauses probably indicating a direct role in 
positively controlling transcription elongation [29, 63-65]. In this 
context, the 7SK snRNP complex appears not to simply be 
an inactive reservoir of P-TEFb but plays a functional role in 
delivering primed kinase to promoter-proximal regions 
containing paused Pol II. 
Interplay between the 7SK snRNP, P-TEFb and cellular 
phosphatases in regulating transcriptional pause release 
In order to accommodate the transcriptional needs of the 
cell, the P-TEFb kinase has to be released from the snRNP 
and then captured by promoter-associated factors to act 
locally on its substrates (Pol II and negative elongation 
factors). Just as Cdk9 T-loop phosphorylation promotes 7SK 
Figure 2. 7SK snRNP complex assembly. The 7SK snRNP 
complex assembles through interactions between P-TEFb 
(phosphorylated on the kinase T-loop, residue T186), the kinase 
inhibitor Hexim (that directly binds 7SK RNA as homo-dimer to tether 
the kinase), and MePCE-Larp7 proteins, which directly bind the RNA 
to protect it from degradation thus making a stable ribonucleoprotein 
complex. 
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snRNP complex assembly, dephosphorylation of the T-loop 
by phosphatases (PPases) induces P-TEFb dislodgement 
from Hexim thereby causing 7SK snRNP disassembly and 
transcriptional pause release (Figure 3). While several 
phosphatases have been identified and proposed to function 
through the 7SK snRNP, the mechanisms (in vitro and in 
vivo) have not been closely examined. In 2008, two papers 
described phosphatases of different families as substrates of 
the P-TEFb kinase [68, 69]. The first Ser/Thr phosphatases to 
be functionally linked to P-TEFb activity control through the 
7SK snRNP were PP2B and PP1 [68], members of the PPP 
phospho-protein family of phosphatases [70]. Both enzymes 
were proposed to cooperatively disrupt the 7SK snRNP 
complex to release P-TEFb for transcription in response to 
Ca2+ signaling [68]. 
Another phosphatase is PPM1A/PP2C, which is a 
member of a large family of metal-dependent phosphatases 
(PPM/PP2C) that participates in diverse biological processes 
[71]. PPM1A overexpression in cells induces 
dephosphorylation of the Cdk9 T-loop [69]. However, the 
biological relevance of this regulatory step in the control of 
P-TEFb activity and Pol II transcriptional pause release, as 
well as the target genes regulated remains to be elucidated. 
More recently, using a biochemical approach, McNamara 
et al. identified another PPM/PP2C family member 
(PPM1G/PP2C) that dephosphorylates the T-loop of Cdk9 
to promote the disassembly of the 7SK snRNP complex in 
vitro (Figure 4). More importantly, PPM1G is recruited to 
gene promoters in response to a variety of environmental 
signals (inflammatory stimuli or DNA damage) through 
interaction with the master transcriptional regulator NF-B 
[29,30]. The study by McNamara et al. represents the first set 
of findings demonstrating a functional link between the 
recruitment of a Cdk9 T-loop phosphatase, 7SK snRNP 
disassembly, and activation of transcriptional pause release 
in response to stimulation in vivo [29]. This report also 
exemplifies a mechanism through which P-TEFb can be 
activated to induce Pol II pause release at a subset of genes in 
response to stimulation. 
Figure 3. P-TEFb dissociation from the 7SK snRNP by the action of phosphatases promotes transcriptional pause release. In 
response to intrinsic/extrinsic stimulus, cell-signaling cascades are activated, and phosphatases (PPase) are induced to promote Cdk9 
T-loop dephosphorylation (P-T186) causing P-TEFb release from the 7SK snRNP complex. However, it remains unclear whether the
PPases function on or off chromatin (or both). Released P-TEFb can then phosphorylate the Pol II CTD on Ser5 (S5) and Ser2 (S2)
residues, DSIF (which is converted into a positive elongation factor), and NELF (which is evicted from Pol II) thereby relieving Pol II stalling
at promoter-proximal regions. Upon 7SK snRNP disassembly, the P-TEFb–free snRNP is repositioned in the promoter-proximal region or
dislodged from chromatin. This aspect of the model requires further investigation (see the text for details). The arrow indicates the position
of the TSS.
RNA & DISEASE 2017; 4: e1215. doi: 10.14800/rd.1215; © 2017 by Swapna Aravind Gudipaty, et al.
http://www.smartscitech.com/index.php/rd 
Page 7 of 12 
The dephosphorylation of Cdk9 T-loop poses a problem 
with the kinase activation state because Cdk9 has to be 
phosphorylated on the T-loop to become active in addition to 
requiring a conformational change in the cyclin subunit 
[48,72,73]. Two different mechanisms have been proposed to 
phosphorylate the T-loop. The first mechanism is through 
Cdk7, which is the TFIIH kinase of the transcription 
pre-initiation complex (PIC) (see Figure 1). Interestingly, 
Cdk7 inhibition increases initiation factor (TFIIE) retention 
at the promoter, prevents DSIF recruitment and attenuates 
Pol II pausing and pause release, due to a reduction in Pol II 
CTD Ser2 phosphorylation and H2B ubiquitylation [41]. The 
second mechanism implies kinase auto-phosphorylation 
induced by the interaction between P-TEFb and transcription 
factors (probably involving major conformational changes) 
[29]. In this context, protein interactions causing the induced 
fit of HIV Tat on P-TEFb exemplifies that transcription 
factors can promote conformational changes on P-TEFb and 
regulate its kinase activity [73, 74]. These are two possible 
mechanisms that describe how P-TEFb (released from the 
7SK snRNP complex) can undergo rapid activation through 
T-loop re-phosphorylation (Figure 4). 
Together, this underscores the importance of 7SK 
snRNP’s recruitment to chromatin and its interplay with 
cellular phosphatases (like PPM1G) to facilitate Pol II pause 
release of target genes in response to environmental 
stimulation. 
Role of PPM1G in relieving transcriptional pausing 
through the 7SK snRNP 
While low levels of PPM1G are detected at 
promoter-proximal regions of inducible or primary 
responsive genes (such as those in the NF-B network), its 
occupancy robustly and temporally increases in response to 
DNA damage stimulation as revealed by kinetic ChIP assays 
[30]. In response to DNA damage signaling, PPM1G 
Figure 4. PPM1G functions through the promoter-assembled 7SK snRNP complex to induce Pol II elongation in response to DNA 
damage signaling. In response to DNA damage signaling, ATM activates the NF-κB signaling pathway (NF-κB binds to target gene 
promoters) and concomitantly phosphorylates PPM1G (P), which in turn dephosphorylates and releases the P-TEFb kinase from the 
promoter-bound 7SK snRNP complex. Upon its release, dephosphorylated P-TEFb becomes re-phosphorylated and activated, and thus 
acts on paused Pol II to induce the transcriptional pause release. After releasing P-TEFb, the inhibitory snRNP subunits are evicted from 
chromatin, and phosphorylated PPM1G (P-S183) binds 7SK RNA along with Hexim (7SK-PPM1G snRNP) to prevent the re-association of 
P-TEFb back into the snRNP to sustain transcription elongation. Once the damage is resolved, this regulatory circuitry subsides, PPM1G is
dislodged from the snRNP (through a yet unknown mechanism), and P-TEFb recycled back to promote the formation of the inhibitory 7SK
snRNP at the promoter-proximal region, thereby blocking Pol II pause release. The arrow indicates the position of the TSS.
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occupancy levels at NF-B target gene promoters rises in 
parallel to the increase in P-TEFb/7SK snRNP. At these 
sites, PPM1G dephosphorylates the T-loop of Cdk9, which 
uncouples it from the kinase inhibitor Hexim, thereby 
causing disassembly of the 7SK snRNP complex, and 
inducing P-TEFb activation and Pol II pause release [29,30] 
(Figure 4). Interestingly, following the release of P-TEFb 
from the 7SK snRNP, we found that PPM1G directly binds 
7SK RNA and forms a heterodimer with Hexim (henceforth 
referred to as “7SK-PPM1G snRNP” to differentiate it from 
the P-TEFb–bound 7SK snRNP complex containing all 
subunits). This mechanism serves to block formation of the 
inhibitory 7SK snRNP complex increasing P-TEFb’s 
availability to participate in multiple rounds of elongation 
(without being sequestered back by Hexim into the 7SK 
snRNP). The PPM1G-7SK RNA interaction is direct, 
kinetically follows the recruitment of PPM1G to target gene 
promoters, and temporally precedes transcription activation, 
supporting its role as a transcriptional co-activator. The 
interaction between PPM1G and 7SK RNA is reversible, 
since PPM1G dissociates from the RNA upon resolution of 
the transcriptional program, thereby allowing for the 
re-sequestration of P-TEFb and Hexim into the snRNP and 
resetting the system to the basal, repressed state, thus 
terminating transcription elongation programs [30]. Thus, the 
reversible nature of the PPM1G-7SK snRNP interaction 
facilitates both the initiation and termination of the 
elongation programs. Together, PPM1G provides a 
functional link between Cdk9 T-loop dephosphorylation and, 
both activation and maintenance of the active transcriptional 
state (an unprecedented regulatory step in transcriptional 
regulation). 
PPM1G is composed of three discrete domains: 
N-terminal, C-terminal phosphatase domain containing a 
Lysine-rich region (Lys), and an intervening acidic-rich 
region. PPM1G uses the Lys-rich region, which bears 
similarity to the Hexim RNA-binding motif [56], to interact 
with the distal region of 7SK RNA stem I. PPM1G binding is 
in close-proximity to the Hexim-binding site, and blocks the 
CCR1 site on Hexim (the site of P-TEFb interaction), which 
is all consistent with formation of Hexim-PPM1G-7SK RNA 
complexes [30, 49, 57, 75]. Together, this suggests that assembly 
of the PPM1G-Hexim protein complex on 7SK RNA 
functions to block P-TEFb binding [30]. 
Several heterogeneous nuclear ribonucleoproteins 
(hnRNP) such as hnRNP A1, A2/B1, R and Q have been 
previously shown to associate with 7SK RNA, but only after 
Hexim and P-TEFb have dissociated from the RNA [76, 77]. It 
would be interesting to determine whether these factors 
function in an analogous manner to PPM1G or whether they 
cooperate with PPM1G and Hexim in preventing P-TEFb 
association into the 7SK snRNP complex to sustain 
transcription elongation. 
PPM1G is required for normal biological processes and 
could prevent malignancy 
The critical role that PPM1G plays in the transcriptional 
cycle and in the control of cell fate choice indicates that its 
malfunction can promote malignancy. Given that DNA 
damage activates the NF-B signaling pathway and that 
PPM1G is a transcriptional co-activator of NF-B, its 
function is essential in maintaining cellular homeostasis. In 
response to DNA damage, PPM1G regulates NF-B–
mediated 7SK RNA–dependent Pol II transcription [30]. 
Consistent with the role of the ataxia telangiectasia mutated 
(ATM) kinase in regulating DNA damage signaling, we 
found that ATM regulates the interaction between PPM1G 
and the 7SK snRNP (by enhancing 7SK RNA interaction) 
through PPM1G site-specific phosphorylation. Due to the 
critical role PPM1G plays in transcription and activation of 
intrinsic and extrinsic pathways it would be interesting to 
determine if cancer-related mutations in the phosphatase 
could act as drivers of malignancy or remain passenger 
genetic alterations. Furthermore, if activation of key cellular 
programs is required to elicit critical responses to a DNA 
insult then it is possible that PPM1G would function as 
tumor suppressor. Honing our understanding about the roles 
PPM1G plays as transcriptional co-activator and in 
preventing the onset of malignancy become critical points as 
we move forward in defining the functional interplay 
between this enzyme and the transcription elongation 
machinery. 
Since PPM1G participates in the activation of NF-B 
programs and NF-B is a critical tumor suppressor or 
oncogene (depending on the stimuli, cell-type, and context 
[78]), PPM1G also emerges as a critical target for diseases 
where NF-B is constitutively activated (such as in chronic 
inflammatory disorders, skin cancers, and leukemias, among 
others). 
Conclusions and future challenges 
A common theme in the field is the identification of 
signaling components/factors that promote the release of 
P-TEFb from the 7SK snRNP to relieve transcriptional 
pausing in what seems to be a highly intricate and dynamic 
process. Although several factors have been linked to 
transcriptional pause release control, little is known about 
how these factors interact with paused Pol II and the 
chromatin environment at promoter-proximal regions. Also, 
it remains unclear what is the role of the transcription factors 
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in linking co-activators to promoters to facilitate pause 
release. Some co-activators functioning to promote 
transcription elongation through the 7SK snRNP complex 
have been recently identified, such as the JMJD6 histone 
demethylase, the bromodomain-containing protein BRD4, 
SR splicing factors, and the RNA helicase DDX21 [64, 67, 79]. 
Nonetheless, PPM1G provides the first example of a cellular 
enzyme that functions through the non-coding RNA to both 
activate and maintain transcription elongation programs [30]. 
PPM1G, compared to other phosphatases described above, is 
the only known phosphatase that has been shown to associate 
with 7SK RNA or other snRNP components to control 
assembly of the 7SK snRNP complex. However, the role of 
other phosphatases cannot be overlooked, as it still remains 
unclear if PPM1G is used as a general transcriptional 
co-activator or only by a subset of P-TEFb–regulated genes 
or under specific regulatory conditions. It is possible that 
other phosphatases could regulate 7SK snRNP dissociation 
and P-TEFb release for transcription elongation under 
different environmental conditions or at different target 
genes. 
Despite the recent remarkable discoveries in the field, 
several critical points remain to be answered. Why 
P-TEFb/7SK snRNP is targeted to promoters and enhancers? 
What is the benefit of having P-TEFb assembled at these 
genomic sites? What does control the timing of kinase 
activation where the substrates are present? How does 
PPM1G encounter its substrate (Cdk9) as part of a larger 
7SK snRNP complex? Furthermore, although the molecular 
and structural details of the interaction between PPM1G and 
7SK snRNP provided important insights in the control of 
transcription elongation, several key questions remain for the 
future. For example: Do posttranslational modifications keep 
the Hexim-PPM1G complex bound to the snRNP? And if 
yes, which enzymes regulate this process? How does PPM1G 
dissociate from Hexim and 7SK RNA to allow re-association 
of P-TEFb and inactivate Pol II pause release? 
Since PPM1G interacts with other snRNP components 
such as MePCE and Larp7 [29], in vitro studies defining the 
stoichiometry and molecular nature of the interactions would 
be beneficial to understand the assembly mechanism and to 
pave the way for future functional studies. Finally, due to the 
critical role of negative elongation factors (NELF and DSIF) 
in the control of Pol II pausing/pause release, whether 
PPM1G enzymatically targets these and other elongation 
factors while preventing escape into productive elongation 
remains to be investigated. In sum, understanding the 
intricate functional interplay between PPM1G, the 7SK 
snRNP, and other transcription co-factors are future 
challenges for the field. 
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